帕金森病患者双重任务训练的有效性:通过元分析进行系统性审查
Héctor García-López1, María de Los Ángeles Castillo-Pintor2, Adelaida María Castro-Sánchez1
1Department of Nursing, Physical Therapy and Medicine University of Almeria Almeria Spain.
Movement disorders clinical practice
|September 29, 2023
概括
双任务训练 (DTT) 改善了帕金森病 (PD) 患者的步态,平衡和运动功能. 这种安全的疗法可以提高步行速度,步长,节奏和平衡,比单任务训练或通常的护理更有效.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 老年学是指老年学的学科.
背景情况:
- 双任务训练 (DTT) 整合了同时进行的运动和认知练习.
- 帕金森病 (PD) 显著影响步态,平衡和运动功能.
研究的目的:
- 评估与单任务训练 (STT) 和PD患者的常规护理 (UC) 相比,DTT的有效性.
- 评估DTT对步态,平衡,运动障碍,日常活动和生活质量的影响.
主要方法:
- 一个随机对照试验 (RCT) 的元分析,遵循PRISMA指南.
- 搜索了主要的数据库 (PubMed,SCOPUS等) 对于将DTT与STT和UC进行比较的RCT.
- 通过PEDro尺度和通过科恩标准化平均差异 (SMD) 聚合效应大小评估方法质量.
主要成果:
- 包括17个RCT和826名参与者;平均PEDro得分为6.59.
- 与STT和UC相比,DTT显著改善了步行速度,步长,节奏和功能平衡.
- 此外,DTT还提高了动态平衡,减少了运动障碍,没有报告的不良影响.
结论:
- 双重任务训练是PD患者的安全有效干预措施.
- 在PD患者中,DTT在改善步态,平衡和运动功能方面表现出卓越的结果.
- 这些发现支持DTT作为帕金森病管理的有价值的治疗策略.
相关概念视频
Parkinson's Disease: Treatment
292
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
292
Parkinson's Disease: Overview
590
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
590


